Felix Karl-Ludwig Klingebiel (Zurich / CH), Yannik Kalbas (Zurich / CH), Sascha Halvachizadeh (Zurich / CH), Michel Paul Johan Teuben (Zurich / CH), Bergita Ganse (Homburg / DE), Paolo Cinelli (Zurich / CH), Hans-Christoph Pape (Zurich / CH), Roman Pfeifer (Zurich / CH)
Introduction
Severe injury is known to have systemic effects at multiple levels, with the inflammatory response being a major focus of research in recent years. However, little is known about the perturbation of metabolic pathways after polytrauma. Therefore, we performed a metabolomic analysis of patients from our in-hospital polytrauma biobank, which contains up to ten days of samples from each patient.
Material & Methods
Patients from the in-house polytrauma biobank with signed ethical consent were utilized. Sample time points were baseline (hospital admission), 8h, 24h, 48h, 5d and 10 days post trauma. Untargeted mass spectrometry was performed, while metabolites reliably identified using the KEGG/HMDB database were subset-analyzed in a semitargeted approach. Metabolic changes were identified using MetaboAnalyst 6.0 to detect pathways that were particularly affected and presented using enrichment ratios.
Results
97 severely injured patients (79.4% male / 20.6% female) were included in the study. The median ISS of this cohort was 29 (IQR=19). 46 metabolites were reliably identified. The immediate response (0-8h) shows increased activation of hemostasis and inflammation along with excessive corticosteroid production. In the 8-24h period, there is an excessive catabolic state with energy mobilization from fatty and amino acids. At 24-48 hours, detoxification, immune regulation and metabolic adjustments are primarily active. In the 5-10 day period, energy requirements are still elevated but reduced compared to the previous time points.
Conclusions
Severe trauma causes a major disruption in the metabolism. Immediately after trauma, the body activates life-saving pathways and begins to mobilize excessive energy resources by breaking down fats and amino acids for ATP production. Initial treatment and intensive care should take this excessive energy demand into account and assess the extent to which organ-protective treatment (e.g. liver) may be beneficial to the patient.
No